Neurodevelopmental disorders, immunity, and cancer are connected

Area of Science:

• Neuroimmunology
• Developmental Neuroscience
• Cancer Biology

Background:

• The immune and nervous systems exhibit co-evolution during embryonic development.
• Immune signaling molecules like cytokines can activate mitogen-activated protein kinase (MAPK) pathways in neural cells.
• Disruptions in these signaling cascades are implicated in both neurodevelopmental disorders and cancer.

Purpose of the Study:

• To explore the commonalities and differences in immune system involvement in neurodevelopmental disorders and cancer.
• To identify shared molecular pathways, such as those involving small GTPases and specific signaling cascades.
• To discuss the implications for drug discovery in these distinct disease areas.

Main Methods:

• Comparative analysis of immune system involvement in neurodevelopmental disorders and cancer.
• Review of signaling pathways including MAPK, TLRs, IL-1, GIT1, and FGFR.
• Examination of the role of small GTPases (Ras, RhoA, Rac) in both conditions.
• Discussion of chromatin organization and gene accessibility alterations.

Main Results:

• Shared involvement of immunity, small GTPases, and specific signaling pathways (TLRs, IL-1, GIT1, FGFR) in neurodevelopmental disorders and cancer.
• Germline/embryonic mutations in neurodevelopmental disorders and somatic mutations in cancer lead to dysregulated signaling.
• Chromatin reorganization and cell type-specific perturbation levels are key differentiating factors.

Conclusions:

• Immunity serves as a common link between neurodevelopmental disorders and cancer.
• Understanding shared signaling pathways and differentiating factors like timing and cell specificity is crucial.
• These insights can inform novel drug discovery strategies for both conditions.